Hyperkalemia: all 124 studies
Page 1 of 2. Open to participants first (25), then studies with results posted, then the rest; newest registration first within each.
- A Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of HyperkalemiaRecruitingNCT07881965Phase 3
- Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot TrialNot yet recruitingNCT07775482Not applicable
- Liberalizing Potassium Restrictions in Patients Receiving HemodialysisNot yet recruitingNCT07772856Not applicable
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationNCT07547878Phase 4
- Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety StudyNot yet recruitingNCT07523867Phase 4
- Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited Potassium Content in Patients With Chronic Kidney Disease: A Pilot StudyRecruitingNCT07494266Not applicable
- Observational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in BrazilRecruitingNCT07370194
- AI-Enabled ECG Stratification and Timing of Potassium-Lowering Therapy in Patients With Hyperkalemia: A Target Trial Emulation StudyNot yet recruitingNCT07307729Not applicable
- A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of HyperkalemiaRecruitingNCT07251309Phase 3
- AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote MonitoringRecruitingNCT07210021
- Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in CommunityRecruitingNCT06940414
- Effects of Minimally vs. Ultra-Processed Diets on Potassium (K) Handling in CKDNot yet recruitingNCT06920914Not applicable
- Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5RecruitingNCT06901960Not applicable
- Patiromer and Diet/hrQoL in Chronic DialysisRecruitingNCT06858280Phase 3
- COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG WearableEnrolling by invitationNCT06763549
- The Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis PatientsNot yet recruitingNCT06736184Phase 4
- Lower vs. Standard Insulin-Dextrose Doses for Treating Mild to Moderate Hyperkalemia in the Emergency DepartmentEnrolling by invitationNCT06724991Not applicable
- Chronic Kidney Disease, Hyperkalemia and Echocardiographic ChangesRecruitingNCT06635590
- Low-potassium Content Vegetables in Chronic Kidney DiseaseRecruitingNCT06428942Not applicable
- Adding Urea to the Final Dialysis FluidRecruitingNCT06366230Phase 1/2
- Sodium Zirconium Cyclosilicate to Allow Liberal Fruit and Vegetable Intake for Patients With CKD Stage 3b and 4RecruitingNCT06365684Phase 4
- A Study to Evaluate the Safety and Efficacy of WS016 in Patients With Hyperkalemia.RecruitingNCT06277128Phase 2
- Potassium Correction for RAAS Optimization in Chronic Kidney DiseaseRecruitingNCT06256991Phase 4
- Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium LevelsRecruitingNCT05766839Phase 2
- An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With HyperkalaemiaRecruitingNCT03813407Phase 3
- Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge StudyCompletedNCT05347693Phase 4Results posted
- A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of HyperkalaemiaTerminatedNCT05056727Phase 3Results posted
- Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With HyperkalaemiaTerminatedNCT04997161Phase 4Results posted
- The ORTIZ Study: Optimising RASi Therapy With SZCTerminatedNCT04983979Phase 2Results posted
- Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)TerminatedNCT04847232Phase 3Results posted
- Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy SubjectsCompletedNCT04788641Phase 1Results posted
- Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney DiseaseTerminatedNCT04727528Phase 3Results posted
- Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving SpironolactoneCompletedNCT04676646Phase 4Results posted
- Reduce Incidence of Pre-Dialysis Hyperkalaemia With Sodium Zirconium Cyclosilicate in Chinese SubjectsCompletedNCT04217590Phase 3Results posted
- Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)CompletedNCT03888066Phase 3Results posted
- Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease PatientsCompletedNCT03781089Phase 4Results posted
- Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Add-OnTerminatedNCT03597035Phase 4Results posted
- A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.CompletedNCT03528681Phase 3Results posted
- A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8CompletedNCT03337477Phase 2Results posted
- The Effects of Patiromer on Serum Potassium Level and Gut Microbiome of ESRD Patients With HyperkalemiaCompletedNCT03326583Phase 2Results posted
- A Study to Test Whether ZS (Sodium Zirconium Cyclosilicate) Can Reduce the Incidence of Increased Blood Potassium Levels Among Dialized Patients.CompletedNCT03303521Phase 3Results posted
- Use of Patiromer to Transition Chronic Kidney Disease Patients With Hyperkalemia to a Plant-rich Diet.CompletedNCT03183778Phase 4Results posted
- Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With HyperkalemiaCompletedNCT03172702Phase 3Results posted
- ZS Ph2/3 Dose-response Study in JapanCompletedNCT03127644Phase 2/3Results posted
- Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and HyperkalemiaTerminatedNCT03087058Phase 2Results posted
- Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney DiseaseCompletedNCT03071263Phase 2Results posted
- Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE)CompletedNCT02933450Phase 4Results posted
- A Study to Investigate the Safety and Efficacy of ZS in Patients With HyperkalemiaCompletedNCT02875834Phase 3Results posted
- Patiromer With or Without Food for the Treatment of HyperkalemiaCompletedNCT02694744Phase 4Results posted
- POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis: A Multicenter, Prospective, Observational StudyCompletedNCT02609841Results posted
- Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 MonthsCompletedNCT02163499Phase 3Results posted
- Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia.CompletedNCT02107092Phase 3Results posted
- Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia.CompletedNCT02088073Phase 3Results posted
- An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on HemodialysisTerminatedNCT02033317Phase 2Results posted
- Safety and Efficacy of Sodium Polystyrene Sulfonate in HyperkalemiaTerminatedNCT01866709Phase 4Results posted
- A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)CompletedNCT01810939Phase 3Results posted
- Safety & Efficacy of Zirconium Silicate in Mild to Moderate HyperkalemiaCompletedNCT01737697Phase 3Results posted
- Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild HyperkalemiaCompletedNCT01493024Phase 2Results posted
- Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)CompletedNCT01371747Phase 2Results posted
- Evaluation of Patiromer in Heart Failure PatientsCompletedNCT00868439Phase 2Results posted
- Nurse-Led Nutritional Education for Moroccan Dialysis PatientsCompletedNCT07277530Not applicable
- Prediction of Hyperkalemia in Dialysis Patients Through Waveform Analysis Using Wearable ECGCompletedNCT07054905
- Hyperkalemia Quality Improvement Program (HK-QIP) StudyActive, not recruitingNCT06884267Not applicable
- VITALIZE.Use and Effectiveness of Sodium Zirconium Cyclosilicate (LokelmaTM) in the Real-world Setting in SpainCompletedNCT06635499
- The Safety and Tolerability of WS016 in Healthy Chinese VolunteersCompletedNCT06281470Phase 1
- A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in GreeceCompletedNCT06185660
- Evidence for Potassium Restriction in HemodialysisActive, not recruitingNCT06120608Not applicable
- 5 Versus 10 Units of Insulin in Hyperkalemia ManagementCompletedNCT06036823Phase 4
- SZC Versus SPS for Treatment of Hyperkalemia in Hemodialysis PatientsCompletedNCT06029179Not applicable
- Dietary Fiber and Hyperkalemia in Dialysis PatientsCompletedNCT05860491
- Patiromer Trial in CKD Stage IIIB to VTerminatedNCT05786469Phase 3
- Nebulized Salbutamol Facilitate Management of Hyperkalemia Postreperfusion During Liver TransplantationStatus unknownNCT05589441Not applicable
- A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic HyperkalemiaCompletedNCT05535920Phase 4
- Safety of Oral Resin for Treatment of Hyperkalemia in Chinese Patients With Renal InsufficiencyCompletedNCT05462119
- A Study to Detect Hyperkalemia Using Smartphone-enabled Electrocardiogram (EKG)CompletedNCT05441852
- Tracking Treatment Pathways in Adult Patients With Hyperkalemia.CompletedNCT05408039
- Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After ParathyroidectomyCompletedNCT05382988Phase 3
- An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart FailureCompletedNCT05297409
- A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety and Treatment Pattern of Sodium Zirconium Cyclosilicate for Hyperkalaemia Management in Real World Practice in ChinaCompletedNCT05271266
- Description of the Clinical Outcomes of Hospitalized Patients With Heart Failure With Different Serum Potassium LevelsCompletedNCT05184998
- Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.Status unknownNCT05173584Phase 4
- Trial Evaluating the Efficacy and Safety of Patiromer in Chinese SubjectsCompletedNCT05136664Phase 3
- Artificial Intelligence Identified Dyskalemia Using Electrocardiogram (AIDE)CompletedNCT05118022Not applicable
- Dietary Potassium Liberalization in Pre-Dialysis PatientsCompletedNCT05090865Not applicable
- Effect of Viscous Fiber on Postprandial Kalemic Response in Hemodialysis PatientsCompletedNCT05086185
- Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant RecipientsCompletedNCT05029310Phase 4
- Retrospective Survey of Hyperkalemia in HemodialysisStatus unknownNCT05020717
- Lokelma for RAAS Maximisation in CKD & Heart Failure.CompletedNCT05004363Phase 3
- A Comparative Study of ZG-801 and Placebo in Patients With HyperkalemiaCompletedNCT04955678Phase 3
- Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of HyperkalaemiaCompletedNCT04864795
- Hyperkalaemia Prevalence, Recurrence and Treatment in HaemodialysisCompletedNCT04799067
- OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart FailureActive, not recruitingNCT04789239Phase 2
- A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of HyperkalemiaCompletedNCT04780841Phase 2
- Potassium Binder in CKD Patients (With Hyperkalemia) (DiPo Trial)Status unknownNCT04727840Phase 1
- Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease and HyperkalaemiaCompletedNCT04566653
- IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System InhibitorsWithdrawnNCT04510792
- Assessment of Hyperkalemia's Illness and Treatment Burden in Chronic Kidney Disease and Heart Failure Patients: HK Registry Pilot StudyCompletedNCT04466969
- Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia ManagementTerminatedNCT04443608Phase 4
- Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum ElectrolytesCompletedNCT04256369
- Clinical Potassium Pilot StudyCompletedNCT04251468Not applicable